E77.0
Defects in post-translational modification of lysosomal enzymes
Clinical Classification Guidelines
Inclusion Terms
- Mucolipidosis II [I-cell disease]
- Mucolipidosis III [pseudo-Hurler polydystrophy]
Medical Intelligence & Overview
ICD-10 code E77.0 refers to disorders characterized by defects in the post-translational modification of lysosomal enzymes, primarily leading to conditions known as Mucolipidosis II and III. These are rare inherited disorders that affect how cells process and break down certain substances. The main consequence is the buildup of complex molecules in various tissues, causing a range of health issues. Mucolipidosis II, also called I-cell disease, and Mucolipidosis III, known as pseudo-Hurler polydystrophy, are part of this group of metabolic disorders.
Causes & Symptoms
Clinical Causes: T h e s e c o n d i t i o n s a r e c a u s e d b y g e n e t i c m u t a t i o n s t h a t l e a d t o d e f i c i e n c i e s o r m a l f u n c t i o n s i n e n z y m e s r e s p o n s i b l e f o r d e g r a d i n g w a s t e m a t e r i a l s i n c e l l s . S p e c i f i c a l l y , t h e m u t a t i o n s i m p a i r t h e p r o c e s s k n o w n a s p o s t - t r a n s l a t i o n a l m o d i f i c a t i o n , w h i c h i s e s s e n t i a l f o r a c t i v a t i n g l y s o s o m a l e n z y m e s . T h e i n h e r i t a n c e p a t t e r n i s t y p i c a l l y a u t o s o m a l r e c e s s i v e , m e a n i n g a p e r s o n m u s t i n h e r i t t w o c o p i e s o f t h e m u t a t e d g e n e , o n e f r o m e a c h p a r e n t , t o b e a f f e c t e d .
Key Symptoms: Abnormal bone development and skeletal deformities Growth delays and short stature Coarse facial features such as a prominent forehead, nose, and jaw Joint stiffness and limited mobility Hearing loss due to middle ear problems Enlarged liver and spleen Corneal clouding affecting vision Delayed development and intellectual disability, especially in Mucolipidosis II
Diagnostic & Treatment
Diagnosis Path: Assessment of physical features and growth parameters Imaging scans such as X-rays to detect skeletal abnormalities Enzyme activity assays to measure the levels and functioning of lysosomal enzymes Genetic testing to identify mutations in relevant genes
Treatment Protocols: Supportive therapies including physical and occupational therapy Surgical interventions to correct skeletal deformities or other structural issues Monitoring and treating complications such as airway problems, hearing loss, or vision issues Regular assessments to track disease progression and adjust care plans accordingly
Clinical Advice & FAQs
Billing Guidance
Is E77.0 a billable ICD-10 code?
Yes, E77.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E77.0?
Clinical documentation must specify the nature of Defects in post-translational modification of lysosomal enzymes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference